Global Capecitabine Market Data Survey Report 2025
- HEY2159375
- 77 Pages
- October 2017
- Healthcare
Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.
The global Capecitabine market will reach Volume Million USD in 2017 with CAGR xx% 2018-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)
Average market price by SUK
Major applications
Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
Teva
Roche
Mylan
Hikma
Hengrui Medicine
Cipla
Reliance Group
Hetero
Major applications as follows:
Breast Cancer
Colorectal cancer
Stomach Cancer
Regional market size, production data and export & import:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Global Market Overview
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.4 Scope of Regions/Countries
1.2 Global Market Size
2 Regional Market
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 Key Manufacturers
3.1 Teva
3.1.2 Company Information
3.1.2 Product Specifications
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 Roche
3.2.1 Company Information
3.2.2 Product Specifications
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 Mylan
3.3.1 Company Information
3.3.2 Product Specifications
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 Hikma
3.4.1 Company Information
3.4.2 Product Specifications
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 Hengrui Medicine
3.5.1 Company Information
3.5.2 Product Specifications
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 Cipla
3.6.1 Company Information
3.6.2 Product Specifications
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 Reliance Group
3.7.1 Company Information
3.7.2 Product Specifications
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 Hetero
3.8.1 Company Information
3.8.2 Product Specifications
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
4 Major Application
4.1 Breast Cancer
4.1.1 Overview
4.1.2 Breast Cancer Market Size and Forecast
4.2 Colorectal cancer
4.2.1 Overview
4.2.2 Colorectal cancer Market Size and Forecast
4.3 Stomach Cancer
4.3.1 Overview
4.3.2 Stomach Cancer Market Size and Forecast
5 Market Price
5.1 Overview
5.2 Price by SUK
6 Conclusion
List Of Tables
Tab Regional Production 2011-2017 (Value)
Tab Regional Production 2011-2017 (Volume)
Tab Regional Demand and CAGR 2011-2017 (Value)
Tab Regional Demand and CAGR 2011-2017 (Volume)
Tab Regional Demand Forecast and CAGR 2018-2025 (Value)
Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)
Tab Regional Export 2011-2017 (Value)
Tab Regional Export 2011-2017 (Volume)
Tab Regional Import 2011-2017 (Value)
Tab Regional Import 2011-2017 (Volume)
Tab Sales Revenue, Volume, Price, Cost and Margin of Teva
Tab Sales Revenue, Volume, Price, Cost and Margin of Roche
Tab Sales Revenue, Volume, Price, Cost and Margin of Mylan
Tab Sales Revenue, Volume, Price, Cost and Margin of Hikma
Tab Sales Revenue, Volume, Price, Cost and Margin of Hengrui Medicine
Tab Sales Revenue, Volume, Price, Cost and Margin of Cipla
Tab Sales Revenue, Volume, Price, Cost and Margin of Reliance Group
Tab Sales Revenue, Volume, Price, Cost and Margin of Hetero
Tab Market Price by Region
Tab Market Price by Manufacturers
Tab Market Price by Application
Tab Price by SUK (Popular Goods on the Market)
List Of Figures
Fig Global Capecitabine Market Size and CAGR 2011-2017 (Value)
Fig Global Capecitabine Market Size and CAGR 2011-2017 (Volume)
Fig Global Capecitabine Market Forecast and CAGR 2018-2025 (Value)
Fig Global Capecitabine Market Forecast and CAGR 2018-2025 (Volume)
Fig Breast Cancer Market Size and CAGR 2011-2017 (Value)
Fig Breast Cancer Market Size and CAGR 2011-2017 (Volume)
Fig Breast Cancer Market Forecast and CAGR 2018-2025 (Value)
Fig Breast Cancer Market Forecast and CAGR 2018-2025 (Volume)
Fig Colorectal cancer Market Size and CAGR 2011-2017 (Value)
Fig Colorectal cancer Market Size and CAGR 2011-2017 (Volume)
Fig Colorectal cancer Market Forecast and CAGR 2018-2025 (Value)
Fig Colorectal cancer Market Forecast and CAGR 2018-2025 (Volume)
Fig Stomach Cancer Market Size and CAGR 2011-2017 (Value)
Fig Stomach Cancer Market Size and CAGR 2011-2017 (Volume)
Fig Stomach Cancer Market Forecast and CAGR 2018-2025 (Value)
Fig Stomach Cancer Market Forecast and CAGR 2018-2025 (Volume)
Fig Global Market Price 2011-2017
Fig Global Market Price 2018-2025
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
